Clinical development of C-peptide for prevention and treatment of diabetes complications
Reference number | |
Coordinator | Cebix AB |
Funding from Vinnova | SEK 75 000 |
Project duration | August 2010 - October 2010 |
Status | Completed |
Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Clinical development of C-peptide for prevention and treatment of diabetes complications
Reference number | 2010-01729 |
Coordinator | Cebix AB |
Funding from Vinnova | SEK 75 000 |
Project duration | August 2010 - October 2010 |
Status | Completed |
Last updated 25 November 2019
Reference number 2010-01729